Warren Center for Neuroscience Drug Discovery
Vanderbilt IP licensed to IPO-prospect Neumora might earn VU millions
Aug 26, 2023 at 12:14 pm by miltcapps
Update: Neumora's IPO went effective March 26, 2025 (NasdaqGS:NMRA).
A PRELIMINARY IPO filing yesterday by Massachusetts-based Neumora Therapeutics lists among company advanta.... Read More
Appello Pharma completes Series A to advance treatment of Parkinson's
Dec 01, 2020 at 05:15 pm by miltcapps
Updated: Jan. 24, 2022: Appello filed for completion of a $13.5MM Series B equity raise.-Ed.
NASHVILLE-BASED Appello Pharmaceuticals Inc. yesterday reported completing its Ser.... Read More